TI
NPCE icon

Trexquant Investment’s Neuropace NPCE Stock Holding History

Trexquant Investment’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$815K Buy
61,969
+22,813
+58% +$342K 0.01% 1298
2025
Q4 		$605K Sell
39,156
-17,880
-31% -$239K 0.01% 1301
2025
Q3 		$588K Buy
57,036
+12,206
+27% +$115K 0.01% 1287
2025
Q2 		$499K Buy
44,830
+21,186
+90% +$265K 0.01% 1269
2025
Q1 		$291K Buy
+23,644
New +$296K ﹤0.01% 1398

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Trexquant Investment's NPCE Position: Q1 2026 in Review

Trexquant Investment increased its Neuropace (NPCE) stake by 58% in Q1 2026, buying an estimated $342K and bringing the position to 61,969 shares worth $815K. The position accounts for 0.01% of the portfolio, ranked #1298.

Trexquant Investment first reported a position in NPCE in Q1 2025 and has held it in 5 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Trexquant Investment held 61,969 shares of Neuropace worth $815K as of Q1 2026.
  • Trexquant Investment bought 22,813 Neuropace shares in Q1 2026, an estimated $342K.
  • Neuropace made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1298 holding.
  • Trexquant Investment first reported a position in Neuropace in Q1 2025 and has held it in 5 quarters since.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.